Insights On Trial Design

  1. The Next Frontier In Early Phase Oncology Trials 10/18/2024

    This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.

  2. On-site ePRO Solutions For Flexible Data Collection Across Devices 3/17/2026

    Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.

  3. FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know 8/24/2026

    FDA's July 2026 final guidance on psychedelic drug clinical investigations sets expectations for sponsors developing psilocybin, LSD, and MDMA therapies. Learn what it means for your program.

  4. How Adaptive Design Accelerates Early‑Phase NSCLC Development 5/22/2026

    Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.

  5. The Future Of Patient Recruitment: Leveraging RWD For Precision 4/25/2025

    To combat the costly challenges of patient recruitment and keep trials on track, sponsors can leverage real-world data.

  6. Automation Testing In RTSM Software: What Is It And What's The Impact 2/25/2026

    Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.

  7. Solutions To The Challenges Of Oncology Trials 5/6/2025

    This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.

  8. Retaining Patients For 13+ Years In DIAD Research 8/14/2026

    Discover how home-based research models can improve accessibility, reduce participant burden, and help sustain engagement over many years, supporting stronger outcomes in longitudinal clinical studies.

  9. Why Team Integration Makes Or Breaks Marketing Applications 4/10/2025

    True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.

  10. Eligibility Criteria For Successful Retinal Study Delivery 1/14/2026

    Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.